BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19389413)

  • 1. Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles.
    Zhou Y; Brigstock D; Besner GE
    Microvasc Res; 2009 Jun; 78(1):78-85. PubMed ID: 19389413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.
    Yu X; Radulescu A; Zorko N; Besner GE
    Gastroenterology; 2009 Jul; 137(1):221-30. PubMed ID: 19361505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats.
    Mazzuca MQ; Dang Y; Khalil RA
    Br J Pharmacol; 2013 Jul; 169(6):1335-51. PubMed ID: 23646960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 in human intestine resected for necrotizing enterocolitis.
    Nowicki PT; Dunaway DJ; Nankervis CA; Giannone PJ; Reber KM; Hammond SB; Besner GE; Caniano DA
    J Pediatr; 2005 Jun; 146(6):805-10. PubMed ID: 15973323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-binding EGF-like growth factor protects pericytes from injury.
    Yu X; Radulescu A; Chen CL; James IO; Besner GE
    J Surg Res; 2012 Jan; 172(1):165-76. PubMed ID: 20863525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.
    Chen CL; Yu X; James IO; Zhang HY; Yang J; Radulescu A; Zhou Y; Besner GE
    Lab Invest; 2012 Mar; 92(3):331-44. PubMed ID: 22157721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.
    Yang J; Watkins D; Chen CL; Bhushan B; Zhou Y; Besner GE
    J Am Coll Surg; 2012 Oct; 215(4):534-45. PubMed ID: 22819639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury.
    Rocourt DV; Mehta VB; Besner GE
    J Surg Res; 2007 May; 139(2):269-73. PubMed ID: 17291530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury.
    Xia G; Rachfal AW; Martin AE; Besner GE
    J Invest Surg; 2003; 16(2):57-63. PubMed ID: 12746188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
    Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
    J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
    Radulescu A; Zorko NA; Yu X; Besner GE
    Pediatr Res; 2009 Apr; 65(4):437-42. PubMed ID: 19127210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
    Martin AE; Luquette MH; Besner GE
    J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats.
    Du QH; Han L; Jiang JJ; Li PT; Wang XY; Jia X
    World J Gastroenterol; 2013 Apr; 19(13):2065-72. PubMed ID: 23599626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells.
    Lara-Marquez ML; Mehta V; Michalsky MP; Fleming JB; Besner GE
    Nitric Oxide; 2002 Mar; 6(2):142-52. PubMed ID: 11890738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
    Xia G; Martin AE; Besner GE
    J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
    Feng J; Besner GE
    J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation.
    El-Assal ON; Radulescu A; Besner GE
    Surgery; 2007 Aug; 142(2):234-42. PubMed ID: 17689691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice.
    El-Assal ON; Paddock H; Marquez A; Besner GE
    J Pediatr Surg; 2008 Jun; 43(6):1182-90. PubMed ID: 18558204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.
    Radulescu A; Zhang HY; Yu X; Olson JK; Darbyshire AK; Chen Y; Besner GE
    J Pediatr Surg; 2010 Oct; 45(10):1933-9. PubMed ID: 20920709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.